Dudediligence.

Caris Life Sciences, Inc

CAINASDAQ · Services-Medical Laboratories
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$101.6MSep ’24$129.9MDec ’24$120.9MMar ’25$181.4MJun ’25$216.8MSep ’25$292.9MDec ’25$216.2MMar ’26$263.7MJun ’26
Net income, by quarter
−$67.7MSep ’24−$36.9MDec ’24−$102.6MMar ’25−$71.8MJun ’25$24.3MSep ’25$82.0MDec ’25−$510,000Mar ’26−$637,000Jun ’26
Fiscal years, by the month each ended
LineDec 2023Dec 2024Dec 2025
Revenue$306.1M$412.3M$812.0M
Operating income−$319.6M−$257.1M$45.1M
Net income−$341.4M−$281.9M−$68.1M
Operating cash flow−$276.1M−$245.2M$83.2M
Free cash flow−$298.4M−$253.6M$66.9M
Cashnone on file$64.0M$796.3M
Debtnone on file$379.5M$379.0M
Shares outstanding34.9M36.5M282.5M